Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative Intravenous Lidocaine for Post-amputation Pain
NCT07783867Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Oct 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Randomised, double-blind trial in postoperative pain, phantom limb pain (PLP) and Residual limb pain (RLP) comparing Lidocaine group with Placebo group (2 arms). Primary endpoint: Incidence of moderate-to-severe movement-evoked pain at 24 hours. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative painphantom limb pain (PLP)Residual limb pain (RLP)
Beyond the preview
Go deeper on NCT07783867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07783867.